#ExaWizardsInc

Through a third-party share allotment raising JPY 5,395,750,000, Sumitomo Mitsui Financial Group acquires a 10.00% voting right stake. Payment is scheduled on 2026-04-16.

As of April 16, 2026, Sumitomo Mitsui Financial Group, Inc. is expected to acquire 9,550,000 shares (10.00% voting rights) through a third-party allotment, becoming a major and the largest major shareholder.

ExaWizards Inc. announced an upward revision of its full-year consolidated earnings forecast for the fiscal year ending March 2026, increasing net sales to 11,900 million yen (0.8% increase from previous forecast) and operating income to 1,500 million yen (11.1% increase).

ExaWizards Inc. announced the planned establishment of its wholly owned subsidiary Exa Frontier Edge with capital of 300 million yen in April 2026, aiming to create a next-generation system development market driven by AI-driven development.

Subsidiary ExaMD submitted a clinical trial notification for the cognitive function AI diagnostic support app to PMDA and commenced clinical trials. Target number of cases is up to 100, with a 3-month subject enrollment period planned.